President Trump tweeted Jan. 2 he had a “much bigger & more powerful” nuclear button on his desk than Mr. Kim, who reportedly said he keeps a nuclear button on his desk at all times.
Demand for potassium iodide, which protects the thyroid from absorbing radioactive iodine, spiked following the tweet, according to distributor Troy Jones, president of Nukepills.com.
“On Jan. 2, I basically got in a month’s supply of potassium iodide and I sold out in 48 hours,” Mr. Jones told KHN. During that two-day period, he shipped out about 140,000 doses of potassium iodide, compared to his usual 8,400 doses.
Another major potassium iodide supplier, Anbex, also saw an increased demand after the president’s tweet. “We are a wonderful barometer of the level of anxiety in the country,” Anbex President Alan Morris told KHN.
While many Americans are buying potassium iodide over fears of a potential nuclear attack, the FDA and CDC do not recommend solely using potassium iodide as an antidote to such a threat. “KI (potassium iodide) cannot protect the body from radioactive elements other than radioactive iodine — if radioactive iodine is not present, taking KI is not protective and could cause harm,” according to the CDC’s website.
More articles on supply chain:
Mylan reaffirms $1B share buyback plan
FDA: IV fluid shortage exacerbated by hurricane damage to Puerto Rico is expected to improve
Stanford Blood Center faces critical shortage of blood, notes the flu is keeping potential donors away
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.